Sanofi-Aventis, Genzyme Are on the Brink of a Merger

by | Feb 7, 2011 | Towing

It seems that months of merger talks between French pharma Sanofi-Aventis and U.S. biotech Genzyme have entered the home stretch. This week, Sanofi is expected to offer $74 a share for Genzyme, with an option included potential…

Sanofi Says MS Drug Reduces Relapses

by | Oct 15, 2010 | Towing

French pharmaceutical giant Sanofi-Aventis says its multiple sclerosis drug teriflunomide significantly cut relapses in patients who took the once-daily oral treatment.
Continue reading Sanofi Says MS Drug Redu…